Is Aducanumab treatment developed to prevent progression of Alzheimer's disease cost-effective in Turkey?

BACKGROUND: Alzheimer's Disease (AD), the most common type of dementia, is a chronic, progressive, and neurodegenerative brain discomfort that causes the be damage to brain cells. Although there is no definitive treatment for AD, various drug treatments are used to reduce and control the sympto...

Descripción completa

Detalles Bibliográficos
Autores principales: Yigit, Vahit, Kalender, Selin, Cetinturk, Iskender
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10410945/
https://www.ncbi.nlm.nih.gov/pubmed/37559042
http://dx.doi.org/10.1186/s12962-023-00463-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10410945/
https://www.ncbi.nlm.nih.gov/pubmed/37559042
http://dx.doi.org/10.1186/s12962-023-00463-7

Ejemplares similares